Elgan Pharma
Israel - NazarethPharmaceutical
Focus: Elgan Pharma is a pharmaceutical company focused on insulin formulation development to treat intestinal malabsorption, operating from Nazareth, Israel with a narrow therapeutic focus in metabolic diseases.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Elgan Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Elgan Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ELGN-2112
Intestinal MalabsorptionClinical Trials (1)
NCT05904626Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
Phase 2Help build intelligence for Elgan Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.